Answers are grounded in this paper and cite their sources.
From a behavioral perspective, therapeutic inertia can happen when obstacles to changing a diabetes treatment plan outweigh perceived benefits. There is a complex interaction of important treatment-related obstacles for people with diabetes (PWD), their treating health care professional (HCP), and the clinical setting in which they interact. Tipping the scales toward more effective action involve strategies that increase perceptions of the benefits of treatment intensification while addressing important obstacles so that treatment changes are seen by both PWD and HCPs as worthwhile and achievable.
No takes yet. Share an insight, caveat, or question.
Susan Guzman (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: